Le Lézard
Classified in: Health
Subjects: CCA, FVT

Regeneron to Report Fourth Quarter and Full Year 2019 Financial and Operating Results and Host Conference Call and Webcast on February 6, 2020


TARRYTOWN, N.Y., Jan. 10, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2019 financial and operating results on Thursday, February 6, 2020, before the U.S. financial markets open.  The Company will host a conference call and simultaneous webcast at 8:00 AM Eastern Time that day.

Conference Call Information
To access this call, dial (800) 708-4540 (U.S.) or (847) 619-6397 (International).  A link to the webcast may be accessed from the 'Investors and Media' page of Regeneron's website at http://investor.regeneron.com/events.cfm.  A replay of the conference call and webcast will be archived on the Company's website for at least 30 days. 

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.

Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, including VelocImmune® which uses a unique genetically-humanized mouse to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world. 


For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Contact Information:


Investor Relations

Corporate Communications

Justin Holko

Hala Mirza

914.847.7786

914.847.3422             

[email protected]

[email protected]

 

SOURCE Regeneron Pharmaceuticals, Inc.


These press releases may also interest you

at 02:00
SSI Schaefer & Noatum Logistics: Success of the Largest Mobile Racking System Installation for Cold Rooms in the UAE
SSI Schaefer, a global leader in warehouse automation and cold-chain storage solutions, is announcing the results of its partnership with Noatum Logistics Middle East, an integrated regional end-to-end logistics services arm of Noatum, an AD...

at 01:48
Korea Zinc announces non-renewal of sulfuric acid consignment contract with Young Poong
The consignment of sulfuric acid originated from Young Poong's Seokpo Smelter adds to the operational risks for Korea Zinc Young Poong has passed the costs and risks associated with sulfuric acid management to Korea Zinc while backlash from the local...

at 01:30
Renowned Industry Expert Peter Kyobe Waiswa Joins XRP Healthcare to transform Private Healthcare in Uganda
XRP Healthcare, a UAE-based M&A healthcare investment and management firm, proudly announces the appointment of Peter Kyobe Waiswa as a Healthcare Industry Expert. Leveraging his vast experience and advisory roles with prominent organizations such as...

at 00:17
Avirmax Inc. to Make Scientific Presentations at ASGCT in Baltimore
Avirmax Inc., will make two scientific presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) annual meeting in Baltimore between May 7th and 11th, 2024. In addition, Avirmax will have an exhibitor booth #818 to showcase the...

at 00:16
The National Council's official statement on the BOP announcement to close FCI Dublin
The National Council for Incarcerated and Formerly Incarcerated Women and Girls understands the BOP has decided to close FCI Dublin. The only humane and ethical way to atone for the atrocities perpetrated there is to let the women who suffered go...

at 00:01
U.S. News Announces 2024 Best Senior Living Ratings
U.S. News & World Report, the global authority in hospital rankings and consumer advice, today revealed its 2024 Best Senior Living ratings to assist seniors and their families with researching and choosing the best senior living community for their...

More news about Health...


News published on and distributed by: